Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020

A Phase 3 study concludes that a simplified regimen of one dose...

Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program

Collaboration to Focus on Rare Genetic and Demyelinating...

Helsinn Group announces AKYNZEO® injection – a new liquid IV solution — now available in the US

Lugano, Switzerland, August 20, 2020 – Helsinn, a...